Our Purpose
The Center for Outcomes Research in Liver Diseases (CORLD) has pioneered in outcomes research related to the areas of patient-reported outcomes (PROs), economic analysis, large database analysis, systematic reviews and meta-analysis involving different types of liver diseases.
About UsThe Global Collaboration in Fatty Liver Disease
Non-alcoholic steatohepatitis (NASH) is increasingly recognized as one of the most common causes of liver disease worldwide. In order to understand the global impact of this disease, CORLD and the Global NASH Councilâ„¢ (GNC) have brought together a large number of world renowned experts with interest in NASH to collaborate and exchange their views about NASH from different regions of the world. These collaborations include most countries from different regions of the world. Members of GNC carry out multiple collaborative projects to better understand NASH, its clinical, economic, societal and PRO burden.
Learn MoreThe Global Registries of NASH and Liver Diseases
Liver disease is among the most common causes of mortality and morbidity worldwide. Although the underlying etiology and causes of liver disease can vary according the region, NASH is rapidly becoming one of the most common causes of liver disease. In order to better understand the burden of NASH and viral hepatitis in different regions of the world, the Global NASH and Liver Registries are developed to enroll subjects with NAFLD, NASH, hepatitis B and C from different regions of the world. Clinical data, laboratory data and PRO questionnaire data are obtained from each patient after informed consent. The de-identified data are entered through a centralized platform and patients are followed by each site on annual basis .
Learn More